Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,605-2,616 of 10,612
Drug study icon
CompletedNCT00490971

Effectiveness of Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Bipolarity

This study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Drug study icon
CompletedNCT04693351

Troriluzole for OCD

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.

In United States
OCDDrugFrom 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT01469039

ALKS 9072 (Also Known for schizophrenia

This study is completed in the United States, in Bulgaria, in Malaysia, .... It is testing ALKS 9072 (Also Known for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States, Bulgaria, Malaysia, ...
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01072929

Armodafinil Treatment for depression

This study is completed in the United States. It is testing armodafinil Treatment for depression.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Cephalon
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02734693

Dasotraline for ADHD

This study is completed in the United States. It is testing dasotraline for ADHD.

In United States
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03231800

Dasotraline for ADHD

This study is completed in the United States. It is testing dasotraline for ADHD.

In United States
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Drug study icon
CompletedNCT07193563

ENX-102 for anxiety

This study is completed in the United States. It is testing ENX-102 for anxiety.

In United States
AnxietyDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Engrail Therapeutics INC
Condition
Anxiety
Drug study icon
CompletedNCT00309699

Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity

This study is completed in the United States, in Greece, in Lithuania, .... It is testing Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Greece, Lithuania, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.